Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Dec 9, 2016
Insider Transaction Report
Form 4
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
- Award
Stock Option (right to buy)
2016-12-07+30,000→ 30,000 totalExercise: $0.49Exp: 2026-12-07→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option grant was approved by Bellerophon Therapeutics, Inc.'s board of directors on December 7, 2016, subject to stockholder approval of an amendment to the stock option plan under which the option was granted.